Impact of Pet Contact on Antimicrobial-associated Dysbiosis and Clostridioides Difficile Infection

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Antimicrobial therapy can lead to disruption of the gut microbiome and infection with Clostridioides difficile, a disease associated with high morbidity and mortality, particularly among the elderly. Drawing on observations that pet ownership and close contact with pets are protective against colonization with C. difficile and recurrence of C. difficile infection, the proposed study will test the hypothesis that microbiota that provide colonization resistance against C. difficile are shared between patients and their pets and that pet contact can mitigate antimicrobial-associated gut dysbiosis and the risk of C. difficile infection. This study will further define epidemiologic and pathophysiologic characteristics of C. difficile infection and gut microbiome dysbiosis that could enhance therapeutic options for these conditions, potentially through non-invasive interventions involving animal contact.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years of age or older.

• Receiving a dental implant.

• Ability to understand study procedures and to comply with them for the entire length of the study.

Locations
United States
Pennsylvania
The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine
RECRUITING
Philadelphia
Contact Information
Primary
Laurel Redding, VMD, PhD
lredding@upenn.edu
6109256307
Time Frame
Start Date: 2022-05-30
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 200
Treatments
Pet owner
Pet owners
Non pet owner
Non pet owners
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Leads: University of Pennsylvania

This content was sourced from clinicaltrials.gov

Similar Clinical Trials